Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
McKinsey
Moodys
Medtronic
Harvard Business School

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Meso-Erythritol

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Meso-Erythritol: Sponsors, patents, clinical trial progress

Meso-Erythritol is an investigational drug.

There have been 18 clinical trials for Meso-Erythritol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2018.

The most common disease conditions in clinical trials are Mesothelioma, Ovarian Neoplasms, and Lung Neoplasms. The leading clinical trial sponsors are Hrain Biotechnology Co.,Ltd., Stony Brook University, and Mbarara University of Science and Technology.

There is one US patent protecting this investigational drug and nineteen international patents.

Recent Clinical Trials for Meso-Erythritol
TitleSponsorPhase
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural MesotheliomaHoffmann-La RochePhase 3
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural MesotheliomaEuropean Thoracic Oncology PlatformPhase 3
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian CancerHrain Biotechnology Co.,Ltd.Early Phase 1

See all Meso-Erythritol clinical trials

Clinical Trial Summary for Meso-Erythritol

Top disease conditions for Meso-Erythritol
Top clinical trial sponsors for Meso-Erythritol

See all Meso-Erythritol clinical trials

US Patents for Meso-Erythritol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Meso-Erythritol   See Pricing Silver halide color photographic material containing sparingly water soluble epoxy compound and organic soluble polymer Fuji Photo Film Co., Ltd. (Kanagawa, JP)   See Pricing
Meso-Erythritol   See Pricing Solvent resistant polyetherpolyurethane products The Dow Chemical Company (Midland, MI)   See Pricing
Meso-Erythritol   See Pricing Silver halide color photographic material having improved dye image stability Fuji Photo Film Co. Ltd. (Tokyo, JP)   See Pricing
Meso-Erythritol   See Pricing Silver halide color photographic material which forms a color photographic image with improved preservability Fuji Photo Film Co., Ltd. (Kanagawa, JP)   See Pricing
Meso-Erythritol   See Pricing Production, isolation, and identification of novel antifungal compounds Board of Trustees Operating Michigan State University (East Lansing, MI)   See Pricing
Meso-Erythritol   See Pricing Acetoacetoxyethyl methacrylate in the cure of epoxy resins Texaco Chemical Company (White Plains, NY)   See Pricing
Meso-Erythritol   See Pricing Low viscosity aromatic carbonate lubricating oil concentrates Exxon Chemical Patents, Inc. (Linden, NJ)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Meso-Erythritol

Drugname Country Document Number Estimated Expiration Related US Patent
Meso-Erythritol Germany 3882303 2007-08-20   See Pricing
Meso-Erythritol European Patent Office 0304810 2007-08-20   See Pricing
Meso-Erythritol Japan H0833634 2007-08-20   See Pricing
Meso-Erythritol Japan S6450049 2007-08-20   See Pricing
Meso-Erythritol Brazil 9005962 2009-03-21   See Pricing
Meso-Erythritol Canada 2012560 2009-03-21   See Pricing
Meso-Erythritol European Patent Office 0418367 2009-03-21   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
AstraZeneca
McKesson
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.